November 5 2020

7:09 pm

Join Us For A Conversation Between Lisa Genova & Greg O’Brien: Dec 1st, 5:30 PM

October 23 2020

VARIATION IN TAU AMONG ALZHEIMER’S PATIENTS MAY EXPLAIN WHY SOME PEOPLE DECLINE AT A FASTER RATE THAN OTHERS

October 23 2020

AMYLYX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN THE PEGASUS TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE

October 23 2020

BRAIN IMAGING STUDY SUGGESTS FEMALE-SPECIFIC RISK FACTORS FOR ALZHEIMER’S DISEASE

October 23 2020

FDA Approves First Tau Imaging Agent For PET Scans For Diagnosis of Alzheimer’s Disease

October 23 2020

How Assessing Blood-Brain Barrier Damage in APOE4 Carriers May Predict Cognitive Decline

Reasons for Hope: Webinar with Dr. Ron Petersen, Alzheimer’s Disease and Clinical Trials

Reasons for Hope: Alzheimer’s Disease and Clinical Trials, Presentation with Dr. Ron Petersen

A Conversation with Dr. Rudy Tanzi on the Latest Clinical Trials and Therapeutics for Alzheimer’s Disease

Panel Presentation: Cure Alzheimer’s Fund Research During the COVID-19 Pandemic

March 20 2020

In Challenging Times, Our Work Continues

February 18 2020

How Could My Wife Have Alzheimer’s? She Was Only 56.